Transfusion and Apheresis Science
Volume 36, Issue 2 , Pages 173-177 , April 2007

What are the indications for plasma exchanges in autoimmune diseases?: The registry of the Société Française d’Hémaphérèse

Received 8 December 2006 ,Accepted 5 January 2007.

References 

  1. Lockwood CM, Rees AJ, Pearson TA, Evans DJ, Peters DK, Wilson CB. Immunosuppression and plasma exchange in the treatment of Goopasture’s syndrome. Lancet. 1976;1(7962):723–726
  2. Gajdos P, Chevret S, Toyka K. Plasma exchange for myasthenia gravis. Cochrane Database Syst Rev. 2002;(4):CD002275
  3. Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C. Plasma exchange and intravenous immunoglobulin in autoimmune myasthenia gravis. Ann NY Acad Sci. 1998;13(841):720–726
  4. Weinshenker BG, O’Brien PC, Petterson TM, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol. 1999;46(6):878–886
  5. Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006;59(3):566–569
  6. Korach J-M, Ould-Zein S, Fadel F, Petitpas D, Chillet P, Berger Ph. Echanges plasmatiques (EP) et microangiopathies thrombotiques (MAT) en France 1991–2003. Réanimation. 2005;14(Suppl. 1):114–115
  7. Coppo P, Bengoufa D, Veyradier A, Wolf M, Bussel A, Millot GA, et al. Reseau d’Etude des Microangiopathies Thrombotiques de l’Adulte. Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement. Medicine (Baltimore). 2004;83(4):233–244
  8. Coppo P, Veyradier A, Fremeaux-Bacchi V. Microangiopathies thrombotiques de l’adulte de plus de 15 ans: établissement d’un registre et étude prospective de l’activité de la protéase spécifique du facteur von-Willebrand et du facteur H. PHRC promoteur AP-HP.
  9. Otsubo S, Tanabe K, Shinmura H, Ishikawa N, Tokumoto T, Hattori M, et al. Effect of post-transplant double filtration plasmapheresis on recurrent focal and segmental glomerulosclerosis in renal transplant recipients. Ther Apher Dial. 2004;8(4):299–304
  10. Deegens JK, Andresdottir MB, Croockewit S, Wetzels JF. Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplant. Transplant Int. 2004;17(3):151–157
  11. Salama AD, Levy JB, Lightstone L, Pusey CD. Goodpasture’s disease. Lancet. 2001;358(9285):917–92015
  12. Josse AG, Kamar N, Bauvin E, Korach JM, Canses-Lauwers V, et al. One-year survival and renal function outcome in patients treated by plasmapheresis for Goodpasture syndrome: a 73 case report study. Neph Dial Transplant. 2003;18(Suppl. 4):70
  13. Pagnoux C, Korach JM, Guillevin L. Indications of plasma exchanges in systemic lupus erythematosus in 2005. Lupus. 2005;14:871–877
  14. Guillevin L. Echanges plasmatiques dans les maladies systémiques: leur place actuelle. Réanimation. 2002;11:359–365
  15. Stegmayr B, Korach JM, Norda R, Rock G, Fadel F. Is there a need for a national or a global apheresis registry. Transfus Apher Sci. 2003;29(2):179–185

PII: S1473-0502(07)00030-4

doi: 10.1016/j.transci.2007.01.007

Transfusion and Apheresis Science
Volume 36, Issue 2 , Pages 173-177 , April 2007

Article Tools

* Image Usage & Resolution